
浏览全部资源
扫码关注微信
东莞东华医院产科
纸质出版日期:2020,
扫 描 看 全 文
[1]余幼辉,马芝萍,朱少群.不同孕激素治疗对先兆早产患者外周血炎症因子水平、妊娠和新生儿结局的影响研究[J].中国医院用药评价与分析,2020,20(07):817-820.
YU Youhui, MA Zhiping, ZHU Shaoqun. Effects of Different Progesterone Therapy on Levels of Peripheral Inflammatory Cytokines,Pregnancy and Neonatal Outcomes in Patients with Threatened Premature Delivery[J]. 2020,20(7):817-820.
[1]余幼辉,马芝萍,朱少群.不同孕激素治疗对先兆早产患者外周血炎症因子水平、妊娠和新生儿结局的影响研究[J].中国医院用药评价与分析,2020,20(07):817-820. DOI: 10.14009/j.issn.1672-2124.2020.07.013.
YU Youhui, MA Zhiping, ZHU Shaoqun. Effects of Different Progesterone Therapy on Levels of Peripheral Inflammatory Cytokines,Pregnancy and Neonatal Outcomes in Patients with Threatened Premature Delivery[J]. 2020,20(7):817-820. DOI: 10.14009/j.issn.1672-2124.2020.07.013.
目的:探讨不同孕激素治疗对先兆早产患者外周血炎症因子水平、妊娠和新生儿结局的影响。方法:选取2018年4月至2019年4月在东莞东华医院产科住院的先兆早产患者120例
根据治疗方案不同分为黄体酮组(采用黄体酮阴道缓释凝胶+盐酸利托君注射液治疗
40例)、地屈孕酮组(采用地屈孕酮片+盐酸利托君注射液治疗
40例)及对照组(采用盐酸利托君注射液治疗
40例)。比较三组患者妊娠结局、新生儿临床结局的差异
记录三组患者外周血炎症因子水平[C反应蛋白(CRP)、白细胞介素6(IL-6)及白细胞介素8(IL-8)]、不良反应发生情况。结果:黄体酮组、地屈孕酮组患者妊娠结局明显优于对照组
分娩妊娠周期较对照组明显延长
差异均有统计学意义(P<0.05);而黄体酮组与地屈孕酮组患者妊娠结局、分娩妊娠周期的差异均无统计学意义(P>0.05)。治疗后
黄体酮组、地屈孕酮组患者CRP、IL-6及IL-8水平明显低于治疗前
差异均有统计学意义(P<0.05);而黄体酮组与地屈孕酮组上述指标的差异均无统计学意义(P>0.05)。三组新生儿平均出生体重、新生儿Apgar评分及脐动脉血气分析pH比较的差异均有统计学意义(P<0.05);黄体酮组、地屈孕酮组新生儿出生体重、新生儿Apgar评分及脐动脉血气分析pH明显高于对照组
差异均有统计学意义(P<0.05)
而黄体酮组与地屈孕酮组上述指标的差异均无统计学意义(P>0.05)。黄体酮组、地屈孕酮组患者的盐酸利托君不良反应发生率明显低于对照组
差异均有统计学意义(P<0.05)
而黄体酮组与地屈孕酮组的差异无统计学意义(P>0.05)。结论:黄体酮阴道缓释凝胶、地屈孕酮片两种孕激素分别联合盐酸利托君注射液用于先兆早产患者的治疗
能减少盐酸利托君注射液的用量和不良反应
降低患者外周血炎症因子水平
有助于改善妊娠和新生儿结局
且效果相近
而地屈孕酮片口服方便
更容易被患者接受。
OBJECTIVE: To probe into the effects of progesterone therapy on levels of peripheral inflammatory cytokines
pregnancy and neonatal outcomes in patients with threatened premature delivery.METHODS: Totally120 patients with threatened premature delivery admitted into Dongguan Donghua Hospital from Apr.2018 to Apr.2019 were extracted to be divided into the progesterone group( received progesterone vagina gel and ritodrine hydrochloride injection
n = 40)
the drogesterone group( received Droxyprogesterone tablets and ritodrine hydrochloride injection
n = 40)
and the control group( received ritodrine hydrochloride injection
n = 40) via different treatment regimens.The pregnancy outcomes and neonatal outcomes of three groups were compared
the serum cytokine levels [C-reactive protein( CRP)
interleukin-6( IL-6)
interleukin-8( IL-8) ] and adverse drug reactions were recorded.RESULTS: The pregnancy outcomes of the progesterone group and the drogesterone group were better than those of the control group
the gestational weeks of delivery were significantly longer than those of the control group
with statistically significant difference( P<0.05).There was no significant difference in gestational weeks and pregnancy outcomes between the progesterone group and the drogesterone group( P>0.05).The levels of CRP
IL-6 and IL-8 in the progesterone group and the drogesterone group after treatment were lower than those before treatment the difference was statistically significant( P< 0.05).There was no significant difference in the levels of CRP
IL-6 and IL-8 after treatment between the progesterone group and the drogesterone group( P>0.05).There were significant differences in average birth weight
Apgar score and pH value of umbilical artery blood gas analysis among three groups( P<0.05).The neonatal birth weight
neonatal Apgar score and pH value of umbilical artery blood gas analysis in the progesterone group and the didrogesterone group were higher than those in the control group( P<0.05).There was no significant difference in neonatal birth weight
neonatal Apgar score and pH value of umbilical artery blood gas analysis between the progesterone group and the didrogesterone group( P >0.05).The incidence of adverse drug reactions in the progesterone group and the dydrogesterone group was significantly lower than that in the control group
the difference was statistically significant( P < 0.05)
and there was no significant difference between the progesterone group and the didrogesterone group( P > 0.05).CONCLUSIONS: Progesterone vagina gel and Droxyprogesterone tablets respectively combined with ritodrine hydrochloride injection in the treatment of patients with threatened premature delivery can reduce the dosage and adverse drug reactions of ritodrine hydrochloride injection
decrease the levels of peripheral inflammatory cytokines
and help to improve the pregnancy and neonatal outcomes.And the effect is similar
and Ditrigesterone tablets are easy to take orally and more easily to be accepted by patients.
孕激素治疗先兆早产妊娠新生儿结局
Progesterone therapyThreatened preterm deliveryPregnancyNeonatal outcomes
0
浏览量
45
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621